InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference

Rhea-AI Summary

InspireMD (Nasdaq: NSPR) will present at the Bank of America Securities 2026 Global Healthcare Conference on Wednesday, May 13, 2026 at 4:20 pm PT. A live audio webcast and archived recording will be available via the company’s Investors page at the provided investor website link.

Market Context

This announcement highlights InspireMD’s participation in a major Bank of America healthcare confere...

Analysis

This announcement highlights InspireMD’s participation in a major Bank of America healthcare conference on May 13, 2026 at 4:20 pm PT, continuing its recent pattern of investor outreach. In the background, the company reported Q1 2026 revenue of $3.4M with a $13.7M net loss, managed a voluntary recall, and secured FDA IDE approval for the CGUARDIANS III trial. An active S-3 shelf and ATM program offer capital-raising flexibility, so monitoring future equity usage and regulatory milestones remains important.

Key Figures

Conference date: May 13, 2026 Presentation time: 4:20 pm PT ATM program size: $75,000,000 +2 more

5 metrics

Conference date May 13, 2026 Bank of America Securities 2026 Global Healthcare Conference presentation

Presentation time 4:20 pm PT Scheduled time for InspireMD’s conference presentation

ATM program size $75,000,000 Equity Distribution Agreement with BTIG under 424B5 filed Apr 3, 2026

Q1 2026 revenue $3.4 million First quarter 2026 results reported May 4, 2026

Q1 2026 net loss $13.7 million Net loss for first quarter 2026

Historical Context

5 past events · Latest: May 04 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 04	Q1 2026 earnings	Neutral	-6.0%	Reported strong revenue growth but ongoing net loss and recall reserves.
May 01	Product recall	Negative	+1.7%	Voluntary U.S. recall of CGuard Prime 135 cm and withdrawal of 2026 guidance.
May 01	FDA IDE approval	Positive	+1.7%	FDA IDE approval for CGUARDIANS III pivotal study of SwitchGuard system.
Apr 27	Earnings date notice	Neutral	-5.8%	Announcement of timing for release of Q1 2026 financial results and call.
Mar 31	Conference participation	Neutral	-3.7%	Planned presentation at the 25th Annual Needham Virtual Healthcare Conference.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news shows mixed reactions: FDA trial approval on May 1 aligned with a positive move, while the product recall the same day saw shares rise despite negative implications. Conference and scheduling announcements have coincided with modest declines.

Recent Company History

Over the last several months, InspireMD has blended commercial rollout and regulatory developments with heightened capital needs. Q1 2026 results on May 4 showed revenue of $3.4M and continued net losses, alongside FDA IDE approval for the CGUARDIANS III trial and recall-related reserves. Earlier in May, a voluntary U.S. recall of CGuard Prime 135 cm and a separate FDA IDE approval both saw a 1.74% move. Prior items included its Q1 2026 earnings date and an April Needham conference appearance, both followed by single‑digit percentage declines. Today’s Bank of America conference participation fits within this pattern of ongoing investor outreach.

Key Terms

carotid stent

1 terms

carotid stent medical

"developer of the CGuard® Prime carotid stent system for the prevention of stroke"

A carotid stent is a small metal mesh tube placed inside a narrowed carotid artery in the neck to prop the vessel open and help restore normal blood flow to the brain, typically delivered through the blood vessels using a thin tube. For investors, it matters because regulatory approvals, clinical trial results, insurance coverage and surgical adoption drive device sales, pricing and legal risk—think of it like a scaffold that keeps a critical pipeline open, affecting demand and revenue for makers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MIAMI, May 06, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard^® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming Bank of America Securities 2026 Global Healthcare Conference on Wednesday, May 13th at 4:20 pm Pacific Time (PT).

A live audio webcast and an archive of the recording will be available through the Investors page of InspireMD’s corporate website at https://investors.inspiremd.com.

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.

Investor Contacts:
Jeff Warren
LifeSci Advisors
jwarren@lifesciadvisors.com
investor-relations@inspiremd.com

FAQ

When will InspireMD (NSPR) present at the Bank of America Securities 2026 Global Healthcare Conference?

InspireMD (NSPR) will present on Wednesday, May 13, 2026 at 4:20 pm Pacific Time (PT). According to InspireMD, the presentation will be available as a live audio webcast and an archived recording on the company Investors webpage for later playback.

How can investors watch the InspireMD (NSPR) presentation on May 13, 2026?

Investors can listen via a live audio webcast and access an archived recording after the event. According to InspireMD, both the live stream and the archive will be posted on the company’s Investors page at the provided investor website link.

What will InspireMD (NSPR) discuss at the Bank of America Securities 2026 Global Healthcare Conference?

The company will present its corporate overview and recent developments during the scheduled session. According to InspireMD, the presentation is intended to outline business progress and product focus, and will be available via a live audio webcast and later archive.

Will the InspireMD (NSPR) webcast be archived for later viewing after May 13, 2026?

Yes, the presentation will be archived after the live session for later access. According to InspireMD, an archive of the audio recording will be posted on the company Investors page so investors can review the presentation on demand.

Where is the InspireMD (NSPR) webcast hosted and posted after the Bank of America conference?

The live audio webcast and archived recording will be hosted on InspireMD’s corporate Investors webpage. According to InspireMD, attendees and investors should visit the company Investors page at the provided investor website link to access the materials.